Even as Adoption of Jabs Fades, More Than 8,000 NEW Covid “Vaccine” Injuries Reported to VAERS

The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,255,355 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and April 29, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.

The data included a total of 27,758 reports of deaths — an increase of 226 over the previous week — and 226,703 serious injuries, including deaths, during the same time period — up 1,937 compared with the previous week. There were 8,224 additional total adverse events reported to VAERS over the previous week.

Excluding “foreign reports” to VAERS, 813,021 adverse events, including 12,779 deaths and 81,271 serious injuries, were reported in the U.S. between Dec. 14, 2020, and April 29, 2022.

Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.

Of the 12,779 U.S. deaths reported as of April 29, 16% occurred within 24 hours of vaccination, 20% occurred within 48 hours of vaccination and 59% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.

In the U.S., 575 million COVID-19 vaccine doses had been administered as of April 29, including 339 million doses of Pfizer, 217 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).

Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.

Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.

U.S. VAERS data from Dec. 14, 2020, to April 29, 2022, for 5- to 11-year-olds show:

U.S. VAERS data from Dec. 14, 2020, to April 29, 2022, for 12- to 17-year-olds show:

• 31,504 adverse events, including 1,808 rated as serious and 44 reported deaths.
  The most recent reported death involves a 14-year-old girl from Tennessee (VAERS I.D. 2238618) who died after receiving her second dose of Pfizer’s COVID-19 vaccine. According to the VAERS report, the girl had a previous history of cancer but was hospitalized 29 days after receiving her second dose of Pfizer with severe COVID-19 and COVID pneumonia. She became “critically ill,” developed respiratory failure and bradycardia and later died.
• 65 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases attributed to Pfizer’s vaccine.
• 650 reports of myocarditis and pericarditis — two fewer than last week — with 638 cases attributed to Pfizer’s vaccine.
• 166 reports of blood clotting disorders — 1 fewer than last week — with all cases attributed to Pfizer.

U.S. VAERS data from Dec. 14, 2020, to April 29, 2022, for all age groups combined, show:

• 20% of deaths were related to cardiac disorders.
• 54% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
• The average age of death was 73.
• As of April 29, 5,480 pregnant women reported adverse events related to COVID-19 vaccines, including 1,711 reports of miscarriage or premature birth.
• Of the 3,626 cases of Bell’s Palsy reported — seven fewer cases than what was reported two weeks ago — 51% were attributed to Pfizer vaccinations, 40% to Moderna and 8% to J&J.
• 872 reports of Guillain-Barré syndrome, with 42% of cases attributed to Pfizer, 30% to Moderna and 29% to J&J.
• 2,331 reports of anaphylaxis — 24 fewer reports than was what recorded two weeks ago — where the reaction was life-threatening, required treatment or resulted in death.
• 1,692 reports of myocardial infarction.
• 13,873 reports of blood-clotting disorders in the U.S. Of those, 6,227 reports were attributed to Pfizer, 4,943 reports to Moderna and 2,662 reports to J&J.
• 4,164 cases of myocarditis and pericarditis with 2,552 cases attributed to Pfizer’s, 1,420 cases to Moderna’s and 180 cases to J&J’s COVID-19 vaccine.